Renal Cancers Recruiting Phase 1 Trials for Durvalumab (DB11714)

Also known as: Cancer, Kidney / Kidney Cancer / Renal Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03983954Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid TumorsTreatment